As shown in Figure 8C, 8F and 8G, expression of phosphorylated RyR2 at Ser2814 were significantly increased in HF and AD-EGFP groups while up-regulation of miR-145 and M+C treatment markedly suppressed the activation of RyR2 (Ser2814). Here, RYR2 is linked to Alzheimer disease.